Locus Biosciences

Locus Biosciences is an emerging biotechnology company in the United States that focuses on discovering and developing next-generation CRISPR-Cas platforms for precision antibacterial drugs. The company's platform combines the antibacterial capabilities of CRISPR-Cas with the efficient and safe delivery of bacteriophages, which are bacterial viruses, enabling doctors to initiate treatment quickly and achieve better medical outcomes.